Fresh Tracks Therapeutics, Inc. — DEFA14A

Fresh Tracks Therapeutics, Inc. of BOULDER, CO filed a DEFA14A with the SEC on 2023-12-19. Industry: Biological Products, (No Diagnostic Substances).

Filing

• Filed: 2023-12-19
• Form: DEFA14A
• Accession: 0001628280-23-042017
• Registrant: Fresh Tracks Therapeutics, Inc.
• CIK: 0000819050
• Industry (SIC): Biological Products, (No Diagnostic Substances) (2836)
• State of incorporation: DE
• Location: BOULDER, CO

Documents (2)

Filing timeline for this registrant (60)

Showing 12 of 60 filings.

More

• CIK 819050 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search